Marinus Pharmaceuticals, Inc. ( MRNS) - Stock Earnings

MRNS Quarterly earnings

DateEarningsRevenue
2024Q1 -38.7 million USD 7.7 million USD
2024Q2 -35.8 million USD 8.1 million USD
2024Q3 -24.2 million USD 8.5 million USD

MRNS Yearly earnings

DateEarningsRevenue
2021 -101.7 million USD 15.3 million USD
2022 -19.8 million USD 25.5 million USD
2023 -141.4 million USD 31.0 million USD

MRNS

Price: $0.55

52 week price:
0.22
10.50

Earnings Per Share: -2.47 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 214200

Ebitda: -19.9 million

Market Capitalization: 30.4 million

Links: